新关注 > 信息聚合 > 200亿美元肾癌药市场谁主沉浮

200亿美元肾癌药市场谁主沉浮

Who will dominate the $20 billion kidney cancer market?

2017-04-14 20:55:54来源: 医药网

医药网4月14日讯 肾细胞癌(RCC)是一种全球范围内常见的恶性肿瘤,简称肾癌。据世界卫生组织数据,全球肾癌发病率占全身性肿瘤的2%~3%。在泌尿系统恶性肿瘤中,其发病率仅次于膀胱癌,且呈逐年上升趋...

Renal cell carcinoma (RCC) is a common malignant tumor worldwide, referred to as renal cancer. According to WHO data, the incidence of renal cell carcinoma in the world accounts for 2% to 3% of systemic tumors. In urological malignancies, its incidence is second only to bladder cancer, and it is increasing year by year.